Supraspinal administration of apelin-13 induces antinociception via the opioid receptor in mice

Peptides

Volumn 30, Issue 6, 2009, Pages 1153-1157

  Xu, Ning ^a   Wang, Haiting ^a   Fan, Li ^a   Chen, Qiang ^a  

^a LANZHOU UNIVERSITY   (China)

Author keywords

Antinociception; Apelin 13; Apelin 13(F13A); Opioid receptor

Indexed keywords

APELIN; APELIN 13; BETA FUNALTREXAMINE; F13A; MORPHINE; MU OPIATE RECEPTOR; NALOXONAZINE; NALOXONE; NALTRINDOLE; NORBINALTORPHIMINE; PROTEIN INHIBITOR; UNCLASSIFIED DRUG;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; MALE; MOUSE; NOCICEPTION; NONHUMAN; PAIN; PRIORITY JOURNAL; TREATMENT RESPONSE;

ANALGESIA; ANALGESICS, OPIOID; ANIMALS; INJECTIONS, INTRAVENTRICULAR; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; MICE, INBRED STRAINS; MORPHINE; PAIN; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, OPIOID; TIME FACTORS;

MUS;

EID: 67349286253     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2009.02.011     Document Type: Article

References (32)

1. Bao G.B., Kang L., Li H.H., Li Y.T., Pu L., Xia P., et al. Morphine and heroin differentially modulate in vivo hippocampal LTP in opiate-dependent rat. Neuropsychopharmacology 32 (2007) 1738-1749
2. Befort K., Filliol D., Darcq E., Ghate A., Matifas A., Lardenois A., et al. Gene expression is altered in the lateral hypothalamus upon activation of the mu opioid receptor. Ann N Y Acad Sci 1129 (2008) 175-184
3. Cayabyab M., Hinuma S., Farzan M., Choe H., Fukusumi S., Kitada C., et al. Apelin, the nature ligand of the orphan seven-transmembrane receptor APJ, inhibits human immunodeficiency virus type 1 entry. J Virol 74 (2000) 111972-111976
4. De Mota N., Lenkei Z., and Llorens-Cortes C. Cloning, pharmacological characterization and brain distribution of the rat apelin receptor. Neuroendocrinology 72 (2000) 400-407
5. Devic E., Rizzoti K., Bodin S., Knibiehler B., and Audigier Y. Amino acid sequence and embryonic expression of msr/apj, the mouse homolog of Xenopus X-msr and human APJ. Mech Dev 84 (1999) 199-203
6. Fang Q., Guo J., Peng Y.L., Chang M., He F., Chen Q., et al. In vitro and in vivo studies of dansylated compounds, the putative agonists and antagonists on neuropeptide FF receptors. Peptides 27 6 (2006) 1297-1304
7. Fu C.Y., Zhao Y.L., Dong L., Chen Q., Ni J.M., and Wang R. In vivo characterization of the effects of human hemokinin-1 and human hemokinin-1(4-11), mammalian tachykinin peptides, on the modulation of pain in mice. Brain Behav Immun 22 6 (2008) 850-860
8. Georgieva D., and Georgiev V. The role of angiotensin II and of its receptor subtypes in the acetic acid-induced abdominal constriction test. Pharmacol Biochem Behav 62 (1999) 229-232
9. Habata Y., Fujii R., Hosoya M., Fukusumi S., Kawamata Y., Hinuma S., et al. Apelin, the natural ligand of the orphan receptor APJ, is abundantly secreted in the colostrums. Biochim Biophys Acta 1452 (1999) 25-35
10. Haley T.J., and McCormick W.G. Pharmacological effects produced by intracerebral injections of drugs in the conscious mouse. Br J Pharmacol 12 (1957) 12-15
11. 125I]-angiotensins in rat. J Neurochem 46 (1986) 1292-1297
12. Horan P., Taylor J., Yamamura H.I., and Porreca F. Extremely long-lasting antagonistic actions of nor-binaltorphimine (nor-BNI) in the mouse tail-flick test. J Pharmacol Exp Ther 260 (1992) 1237-1243
13. Horiuchi Y., Fujii T., Kamimura Y., and Kawashima K. The endogenous, immunologically active peptide apelin inhibits lymphocytic cholinergic activity during immunological responses. J Neuroimmunol 144 (2003) 46-52
14. Hosoya M., Kawamata Y., Fukusumi S., Fujii R., Habata Y., Hinuma S., et al. Molecular and functional characteristics of APJ. Tissue distribution of mRNA and interaction with the endogenous ligand apelin. J Biol Chem 275 (2000) 21061-21067
15. Kawamata Y., Habata Y., Fukusumi S., Hosoya M., Fujii R., Hinuma S., et al. Molecular properties of apelin: tissue distribution and receptor binding. Biochim Biophys Acta 1538 (2001) 162-171
16. Lee D.K., Cheng R., Nguyen T., Fan T., Kariyawasam A.P., Liu Y., et al. Characterization of apelin, the ligand for the APJ receptor. J Neurochem 74 (2000) 34-41
17. Lee D.K., Saldivia V.R., Nguyen T., Cheng R., George S.R., and O'Dowd B.F. Modification of the terminal residue of apelin-13 antagonizes its hypotensive action. Endocrinology 146 (2005) 231-236
18. Lutfy K., Eitan S., Bryant C.D., Yang Y.C., Saliminejad N., Walwyn W., et al. Buprenorphine-induced antinociception is mediated by μ-opioid receptors and compromised by concomitant activation of opioid receptor-like receptors. J Neurosci 23 (2003) 10331-10337
19. Lutfy K., and Maidment N.T. Blockade of μ-opioid receptors reveals the hyperalgesic effect of orphanin FQ/nociceptin in the rat hot plate test. Br J Pharmacol 131 (2000) 1684-1688
20. Medhurst A.D., Jennings C.A., Robbins M.J., Davis R.P., Ellis C., Winborn K.Y., et al. Pharmacological and immunohistochemical characterization of the APJ receptor and its endogenous ligand apelin. J Neurochem 84 (2003) 1162-1172
21. O'Carroll A.M., Selby T.L., Palkovits M., and Lolait S.J. Distribution of mRNA encoding B78/apj, the rat homologue of the human APJ receptor, and its endogenous ligand apelin in brain and peripheral tissues. Biochem Biophys Acta 1492 (2000) 72-80
22. O'Dowd B.F., Heiber M., Chan A., Heng H.H., Tsui L.C., Kennedy J.L., et al. A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11. Gene 136 (1993) 355-360
23. Pelegrini-da-Silva A., Martins A.R., and Prado W.A. A new role for the renin-angiotesin system in the rat periaqueductal gray matter: angiotensin receptor mediated modulation of nociception. Neuroscience 132 (2005) 453-463
24. Raghavendra V., Chopra K., and Kulkarni S.K. Brain renin angiotensin system (RAS) in stress-induced analgesia and impaired retention. Peptides 20 (1999) 335-342
25. Reaux A., De Mota N., Skultetyova I., Lenkei Z., El Messari S., Gallatz K., et al. Physiological role of a novel neuropeptide, apelin, and its receptor in the rat brain. J Neurochem 77 (2001) 1085-1096
26. Reaux A., Gallatz K., Palkovits M., and Llorens-Cortes C. Distribution of apelin-synthesizing neurons in the adult rat brain. Neuroscience 113 (2002) 653-662
27. Seyedabadi M., Goodchild A.K., and Pilowsky P.M. Site-specific effects of apelin-13 in the rat medulla oblongata on arterial pressure and respiration. Auton Neurosci 101 (2002) 32-38
28. Stamidis H., and Young G.A. Naltrindole retards tolerance development to morphine-induced effects on EEG and EEG power spectra. Eur J Pharmacol 213 (1992) 9-16
29. Taheri S., Murphy K., Cohen M., Sujkovic E., Kennedy A., Dhillo W., et al. The effects of centrally administered apelin-13 on food intake, water intake and pituitary hormone release in rats. Biochem Biophys Res Commun 291 (2002) 1208-1212
30. Tatemoto K., Hosoya M., Habata Y., Fujii R., Kakegawa T., Zou M.X., et al. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun 251 (1998) 471-476
31. Tatemoto K., Takayama K., Zou M.X., Kumaki I., Zhang W., Kumano K., et al. The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism. Regul Pept 99 (2001) 87-92
32. Wang G., Anini Y., Wei W., Qi X., O'Carroll A.M., Mochizuki T., et al. Apelin: a new enteric peptide: localization in the gastrointestinal tract, ontogeny, and stimulation of gastric cell proliferation and of cholecystokinin secretion. Endocrinology 145 (2004) 1342-1348